The ataxia-telangiectasia gene product may modulate DNA turnover and control cell fate by regulating cellular redox in lymphocytes

Citation
Ms. Yan et al., The ataxia-telangiectasia gene product may modulate DNA turnover and control cell fate by regulating cellular redox in lymphocytes, FASEB J, 15(7), 2001, pp. 1132-1138
Citations number
31
Categorie Soggetti
Experimental Biology
Journal title
FASEB JOURNAL
ISSN journal
08926638 → ACNP
Volume
15
Issue
7
Year of publication
2001
Pages
1132 - 1138
Database
ISI
SICI code
0892-6638(200105)15:7<1132:TAGPMM>2.0.ZU;2-6
Abstract
The ATM kinase, when activated postnatally, exerts multiple functions to pr event the onset of ataxia-telangiectasia (AT), Using freshly isolated thymo cytes from Atm-/- mice that were under stress during postnatal differentiat ion, we noted that thiol redox activity, as indicated by reduction of the t ebrazolium MTS, and DNA turnover activity, as indicated by incorporation of [H-3]thymidine into DNA, were both greatly increased compared with activit ies in thymocytes from Atm+/+ mice, This increased thymidine incorporation could be suppressed by the thiol N-acetylcysteine, In primary noncycling sp lenocytes, mitogens proportionally increased both the rate of [H-3]thymidin e incorporation and the rate of reduction of MTS, The mitogen-induced activ ities in splenocytes were not affected by ATM but were suppressed by the ca lcineurin-dependent inhibitor FK-506, which has no effect on these activiti es in thymocytes, These findings suggest that increased [H-3]thymidine inco rporation and reducing power indicate increased cell cycling in mitogenical ly stimulated splenocytes, whereas these two indicators represent increased FK-506-independent DNA turnover activities in thymocytes, Thus, a primary function of ATM is to activate the redox-sensitive checkpoint required for down-regulation of DNA turnover activities in developing lymphocytes, Cell- cycling checkpoints in undamaged quiescent lymphocytes are not activated by ATM with mitogenic stimulation. ATM may suppress abnormal DNA turnover and the resultant oncogenesis by regulating cellular thiol redox pathways.